The inactivation of KEAP1 promotes cancer growth and metastasis [37] and is associated with resistance to not only cytotoxic anticancer agents and radiotherapy but also ICIs because the inactivation of the KEAP1 gene results in immunologically cold tumors [38]. The gene discussed is KEAP1; the disease is cancer.